Clinical Trial: Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Brief Summary: The purpose of this study is to determine whether gevokizumab is effective in the treatment of moderate to severe acne vulgaris.
Detailed Summary:
Sponsor: XOMA (US) LLC
Current Primary Outcome: The mean absolute change from baseline in inflammatory facial lesion count at Day 84 [ Time Frame: Baseline and Day 84 ]
Original Primary Outcome: Same as current
Current Secondary Outcome: The proportion of subjects with a successful treatment outcome at Day 84 [ Time Frame: Baseline and Day 84 ]
Original Secondary Outcome: Same as current
Information By: XOMA (US) LLC
Dates:
Date Received: December 21, 2011
Date Started: December 2011
Date Completion:
Last Updated: March 3, 2014
Last Verified: March 2014